Attached files
file | filename |
---|---|
EXCEL - IDEA: XBRL DOCUMENT - Molecular Templates, Inc. | Financial_Report.xls |
10-Q - FORM 10-Q - Molecular Templates, Inc. | d340942d10q.htm |
EX-31.2 - SECTION 302 CFO CERTIFICATION - Molecular Templates, Inc. | d340942dex312.htm |
EX-10.1 - LICENSE AND CO-DEVELOPMENT AGREEMENT - Molecular Templates, Inc. | d340942dex101.htm |
EX-32.2 - SECTION 906 CFO CERTIFICATION - Molecular Templates, Inc. | d340942dex322.htm |
EX-31.1 - SECTION 302 CEO CERTIFICATION - Molecular Templates, Inc. | d340942dex311.htm |
Exhibit 32.1
THRESHOLD PHARMACEUTICALS, INC.
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Threshold Pharmaceuticals, Inc (the Company) on Form 10-Q for the quarter ended March 31, 2012, as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Harold E. Selick, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: May 3, 2012
/s/ Harold E. Selick |
Harold E. Selick, Ph.D. |
Chief Executive Officer |